NASDAQ
Nabriva Therapeutics plc (NBRVF) has a free cash flow growth of 109.09% as of Friday, May 29, 2026. This represents a 534.92% increase compared to its 12-month average of -25.08%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.